Quarterly report [Sections 13 or 15(d)]

NON CONTROLLING INTEREST (Details Narrative)

v3.26.1
NON CONTROLLING INTEREST (Details Narrative) - shares
1 Months Ended
Mar. 26, 2026
Oct. 31, 2020
Jul. 28, 2016
BioCorRx Pharmaceuticals, Inc [Member]      
Ownership percentage held by company     75.80%
Ownership percentage held by former officers     24.20%
BioCorRx Inc. [Member]      
Common stock shares issued in exchange 2,263,371    
Ownership interest 12.15%    
Joseph DeSanto MD [Member]      
Descirption of management services agreement   a management fee equal to 65% of the Medical Corporation’s gross collected monthly revenue